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AgingProduction of reactive oxygen species (ROS) is a tightly regulated process, and increased levels of ROS within
mitochondria are the principal trigger not only for mitochondrial dysfunctions but, more in general, for the
diseases associated with aging, thus representing a powerful signaling molecules. One of the key regulators of
ROS production, mitochondrial dysfunction, and aging is the 66-kDa isoform of the growth factor adapter shc
(p66shc) that is activated by stress and generates ROS within the mitochondria, driving cells to apoptosis.
Accordingly, p66shc knockout animals are one of the best characterized genetic model of longevity.
On the other hand, caloric restriction is the only non-genetic mechanism that is shown to increase life span.
Several studies have revealed a complex network of signaling pathways modulated by nutrients, such as IGF-
1, TOR, sirtuins, AMP kinase, and PGC-1α that are connected and converge to inhibit oxidative stresses within
the mitochondria. Animal models in which components of these signaling pathways are induced or silenced
present a general phenotype characterized by the deceleration of the aging process. This review will
summarize the main ﬁndings in the process that link mitochondria to longevity and the connections between
the different signaling molecules involved in this intriguing relationship..
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Mitochondria, oxidative stress, and aging
The decline associated with aging seems to be caused by the
accumulation of defects in metabolic pathways accompanied by the
accumulation of reactive oxygen species (ROS). More than 50 years
ago, Harman,with his “free radical theory” of aging [1], postulated that
the gradual accumulation of damage within cellular macromolecules
during aging could be ascribed to deleterious effects of free radicals
produced by aerobic metabolism. Thus, although mitochondria exert
the essential role of producing most cellular ATP, they are also the
primary source of cellular reactive oxygen species. For this reason,
mitochondria have been identiﬁed as key players of the aging process,
and Harman himself renamed his proposal the “mitochondrial theory
of aging” [2]. Indeed, it has been shown that mitochondria not only
represent the major source of ROS production but are also the major
targets for their damaging effects, although the relationship between
mitochondria dysfunctions observed during aging and ROS production
is still debated. However, it is clear that the decline of the integrity of
mitochondria as a function of age is implicated in aging and age-
related diseases, such as diabetes, neurodegeneration, and cancer [3].
The production of mitochondrial ROS is a consequence of oxidative
phosphorylation at the respiratory chain complexes I and III, where
electrons derived fromNADHand FADH candirectly reactwith oxygen
or other electron acceptors and generate free radicals [4–6]. Indeed,the increase of the redoxpotential at complex I and complex III induces
ROS generation [7,8].
Mammalian cells have developed during evolution a sophisticated
defense system for scavenging ROS to non-toxic forms that includes
catalase, glutathione reductase, and glutathione peroxidase [9] and the
manganese containing superoxide dismutase (SOD),which is themain
antioxidant of the cell. The cell contains two SOD enzymes: MnSOD or
SOD2 that localizes in the mitochondrial matrix and SOD1 in both the
mitochondrial inner membrane space and in the cytoplasm. The life
span extension of transgenic animal models of these enzymes
consolidated the link betweenROS production and longevity, although
this hypothesis is still controversial [10]. One of the most striking
example that supports the oxidative damage theory of aging comes
from the analysis of the over-expression of MnSOD in Drosophila
melanogaster that was shown to have beneﬁcial effects, extending life
span [11]. Furthermore, the tissue-speciﬁc over-expression of SOD1 in
motor neurons was sufﬁcient to mediate the same effect [12].
Conversely, complete ablation of this enzyme in mice causes severe
oxidative damage to mitochondria and early postnatal death associ-
ated with dilated cardiomyopathy and neurodegeneration [13,14],
although thismodel does not directly prove the link betweenoxidative
damage and aging. Another indirect proof that links ROS production
and aging comes from the observation that different transgenic mice
with extended life span present a common induction in MnSOD
activity, enhancing the efﬁciency of the response to ROS production
[15,16]. Furthermore, mice over-expressing a mitochondria-targeted
catalase not only show increased life span [17], but also present a
reduction of ROS generation, age-associated pathologies, oxidative
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mice for the mitochondrial form of thioredoxin, thioredoxin 2 (Trx2),
die during embryonic development, while the heterozygote animals
present a considerable increase of mitochondrial ROS [18]. In some
studies, the results do not support the hypothesis of the relationship
between ROS and aging [19]. For example, in Caenorhabditis elegans,
knocking down SOD protects against oxidative stress without
prolonging life span [20].
It has been extensively shown in a variety of animalmodels [6] that
during aging, this potent antioxidant defense is disrupted by age-
related diseases, leading to damages to lipids, proteins, and DNA.
Mitochondrial DNA (mtDNA) seems to be highly vulnerable to
oxidative challenges compared to nuclear DNA because of its close
proximity to the electron transport chain (ETC), the main source of
ROS, and of the limited capacity of DNA repair strategies and the lack of
protection by histones [21]. Mitochondria DNA encodes polypeptides
of the ETC and components of mitochondrial protein synthesis
machinery, and therefore, any coding mutations will affect either the
assembly or the function of the ETC components, leading to pleiotropic
effects in the cell. Mitochondrial DNA mutations that reduce the
accuracy of electron transfer increase the likelihood of ROS production
and further mtDNA damage, leading to a “vicious cycle” of exponen-
tially increasing oxidative damage and dysfunction. Recent mouse
models have further implicated mtDNA mutations in the aging
process. One of the most striking examples comes from the analysis
of the knock-in mice that express a proofreading-deﬁcient form of the
nuclear encoded mitochondrial DNA polymerase (Polg) [22]. These
mice show a consistent increase in mtDNA mutations and deletions
that is associatedwith a considerably reduced life span and premature
onset of the aging-related phenotype. Surprisingly, these mice do not
show increased levels of ROS production [23]. This might suggest that
either the dramatic aging phenotype observed in these mice is not
associated with mitochondrial ROS production or that the large
number of mtDNA mutations prevents the correct synthesis and
assembly of the ETC, thus eliminating the principal site of ROS
generation. These and other studies fail to deﬁnitively prove the
causative link between mtDNA mutation, ROS production, and aging
[19]. It is noteworthy to point out that these studies do not take into
account the effects of mtDNA mutations during embryonic develop-
ment, and this issue can be resolvedwith the future characterization of
inducible transgenic animals.
ROS are not only the ﬁnal result of the oxidative stress accumulated
during aging, but they are believed to play a signiﬁcant role in the
regulation of different signaling pathways [24]. For example, it has
been shown that an oxidative burst is required for the modulation of
the insulin/IGF-1 pathway [25] and vascular endothelial growth factor
(VEGF) signaling [26], inducing reversible protein modiﬁcations, such
as disulﬁde bonds or oxidation of cysteinyl thiols [27]. This idea
strengthens the hypothesis that ROS generation has important
signaling functions and underlines the importance of the study of
themechanisms responsible for their production and the physiological
regulation of the downstream signaling pathways.
2. Oxidative stress and p66shc
Given the wide scientiﬁc evidence that highlights mitochondria as
the key regulator of longevity, many groups have focused their efforts
on the identiﬁcation of themechanisms responsible for the deleterious
effects of mitochondrial ROS production on the aging process and on
the molecular pathways responsible for their generation.
An interesting mitochondrial effector is the 66-kDa isoform of the
growth factor adapter shc (p66shc), whichwas demonstrated to directly
mediate the production of ROS within the mitochondria [28]. Three
growth factor adapter shc isoforms have been identiﬁed in mammals,
the 46-, 52-, and 66-kDa shc proteins (p46shc, p52shc, p66shc) [29,30].
They control a wide variety of crucial cell functions, such as growth[31–33], apoptosis [34–38], and life span [39]. Homologues of these
three isoforms have also been identiﬁed in Drosophila and C. elegans,
suggesting an evolutionarily conserved role for shc proteins [29]. All
thee isoforms are generated from the same RNA by splicing or
alternative translation initiation [32]. The importance of shc in vivo
has been demonstrated by the knockout animals of the shc locus, which
results in embryonic lethality [40]. These groups of proteins are deﬁned
as “adaptor proteins” because they bind phosphorylated tyrosines of
growth factor receptors [32] through the PTB and SH2 domains [32].
p46shc and p52 shc, upon phosphorylation on the central region of the
protein (CH1) [30], associate with Grb2 adaptor protein [41,42].
Recruitment of theGrb2–SOS complex is sufﬁcient to inducemembrane
localization of SOS, Ras activation [43], and MAP kinase activity [31],
thus inducing cell proliferation.
The p66 isoform of shc proteins has been the last to be discovered.
This protein shares the PTB/SH2 and the CH1 domains but is
characterized by an additional CH region (CH2) localized at the
N-terminus of the protein that undergoes serine phosphorylation
[31,32]. Similarly to p46shc and p52shc, activated p66shc binds to Grb2
and subsequently to SOS [31,44] but does not stimulate the Ras and
MAP kinase pathways and cell proliferation [31] and rather partici-
pates in intracellular pathways that control oxidative stress, apoptosis,
and life span determination [34–37,39]. p66shc is serine-phosphory-
lated within the unique CH2 region upon treatment with hydrogen
peroxide (H2O2) or irradiation with ultraviolet light (UV) [39].
Cultured ﬁbroblasts from p66shc knockout mice are resistant to UV
and H2O2-induced apoptosis, in a p53-dependent pathway [35], and
thesemice showa considerable increase in life span (about 30%), being
more resistant to oxidative stress induced by paraquat [39]. Impor-
tantly, they are protected against age-dependent, ROS-mediated
endothelial dysfunction [45,46] and against cardiac stem cells aging
and heart failure induced by diabetes [47].
p66shc localizes predominantly in the cytoplasm with a small
fraction localized in the mitochondrial intermembrane space
[36,38,48]. Upon oxidative stress signals, cytosolic p66shc migrates to
the mitochondria [36,38,48] through the interaction with TOM/TIM
import complex and the mitochondrial heat shock protein mtHsp70
[38], where it associates to cytochrome c acting as an oxidoreductase,
thus generating ROS [36]. Indeed, over-expression of p66shc increases
ROS production while its ablation is sufﬁcient to decrease the level of
reactive oxygen species [49]. Importantly, expression of p66shc is
required for themitochondria release of cytochrome c and the opening
of the permeability transition pore (PTP), two crucial steps of the
apoptosis process [36], that plays a central role in the aging process.
Indeed, the degenerative processes that arise in old organisms are
partly caused by increased cell death of non-dividing cells [50], and it is
clear that mitochondria is a crucial regulator of this process because of
their ability to release critical factors in the cytoplasm, where they
activate caspases that drive the cells to the apoptotic process [51].
Moreover, p66shc knockout cells show a reduction in both resting and
maximal oxidative capacity and an induction of glycolysis, strongly
indicating that p66shc may extend life span by shifting energy
conversion toward glycolytic pathways, thus reducing mitochondrial
generation of ROS [48]. These data conﬁrm the existence of a close link
between energetic metabolism, oxidative stress, and aging, as
hypothesized in the mitochondrial theory of aging.
The mechanisms by which p66shc increases intracellular ROS
levels, inducing apoptosis and the deleterious effects of aging has
recently been clariﬁed ([37] and Fig. 1). The translocation of p66shc to
the mitochondrial intermembrane space in response to oxidative
stress is promoted by the activation of PKCβ. The protein kinase C
(PKC) family of proteins consists of 10 related serine/threonine
kinases, some of which are critical regulators of cell proliferation,
survival, and cell death [52]. PKCβ has been proven to be activated
during oxidative stress and to induce the phosphorylation of p66shc on
Ser36 ([37] and Fig. 1). Phosphorylated p66shc is then recognized by
Fig. 1. p66shc signaling pathway. Upon cellular stress (e.g., oxidative stress), PKCβ is
activated and phosphorylates p66shc on Ser36. This modiﬁcation allows the recognition
and the binding of Pin1 that isomerizes p66shc. Subsequently, p66shc is depho-
sphorylated by PPA2 and imported in the mitochondria where it binds to cytochrome c
and acts as an oxidoreductase, shuttling electrons from cytochrome c to molecular
oxygen. Thus, the activation of p66shc induces ROS production and aging.
Fig. 2. Caloric restriction signaling pathways. Caloric restriction increases life span by
downregulating the IGF-1 pathway leading to the activation of FoxO transcription
factors that migrate to the nucleus and induce the transcription of antioxidant genes
(e.g., mitochondrial SOD2). FoxO can be deacetylated and thus activated by SIRT1
whose activity is modulated by CR. SIRT1 modulates also PGC-1α, which improves
mitochondrial dysfunction and promotes mitochondrial biogenesis. PGC-1α is also
directly activated by phosphorylation by AMPK that is the master nutrient sensor in the
cell. All these signals induce the expression of genes involved in stress response, which
act to decrease mitochondrial ROS production extending life span. Caloric restriction
modulates also the autophagic process through different mechanisms. The IGF-1
pathway controls autophagy, indeed TOR activates while FoxO inhibits this process. In
parallel, SIRT1, both by direct stimulation and by modulating FoxO activity, induces
autophagy during caloric restriction.
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thus allowing the import into mitochondria after dephosphorylation
by type 2 protein serine/threonine phosphatase (PP2A) (Fig. 1). The
imported p66shc causes alterations of mitochondrial Ca2+ responses
and of three-dimensional structure, thus inducing ROS production,
mitochondria fragmentation, release of cytochrome c, and apoptosis
[36].
The existence of this alternative redox reaction, bypassing the
mitochondrial electron transfer chain and generating mitochondrial
ROS in response to speciﬁc stress signals, supports the role of these
oxygen species as potent signaling molecules. This hypothesis is
further strengthened by the recent discovery that p66shc induction of
ROS generation within the mitochondria regulates insulin signaling in
adipocytes and fat development [53]. In this study, it was reported
that insulin activates p66shc redox activity, thus generating ROS that in
turn affect the insulin signaling cascade in favor of a reduction of
mitochondrial oxygen consumption and an induction of fat develop-
ment [53]. These data suggest that the p66shc signaling pathway is a
major determinant of mammalian energetic metabolism and shed
light on the apparent contrast between the deleterious effects on life
span of p66shc with the positive selection of this gene during
evolution. Indeed, the p66shc knockout animals were found to have
impaired thermo-regulation caused by a reduction of fat mass of both
white and brown adipose tissues [53], not explainable with changes in
food intake, intestinal absorption of nutrients, or locomotor activities
[53]. Therefore, adaptation to cold as well as optimization of energy
storage in fed conditions could be evolutionary conserved functions
that preserve the p66shc gene in mammals.
3. Caloric restriction and its connection to oxidative stress
Many mutations that extend life span affect not only stress-
response genes, such as p66shc, but also nutrient sensors. Caloric
restriction (CR) is the best example of signals that modulate the
activity of these sensors, and it has been extensively proven that it is
the only non-genetic intervention capable of promoting longevity in
many species, from yeast to rodents. In higher organisms, CR reduces
the incidence of age-related disorders, such as diabetes, cardiovascu-
lar disease, and cancer [54,55].
The idea that caloric restriction regulates life span by reducing the
metabolic rate and thus diminishing the accumulation of macromole-
cule damage over time has been substituted in the past 10 years with
the concept that caloric restriction modulates the activity of several
signaling pathways that have been highly conserved during evolutionfrom yeast to humans (Fig. 2). Although the molecular mechanisms by
which CR promotes longevity are still not clear, its beneﬁcial impact on
mitochondrial function is well established. Indeed, it has been shown
that CR causes a signiﬁcant reduction in mitochondrial ROS production
and oxidative damage and it induces mitochondrial biogenesis in
differentmousemodels [56–59]. It is known that the response todietary
restriction is regulated by AMP kinase (AMPK), sirtuins, insulin growth
factor (IGF-1), and target of rapamycin (TOR) protein kinase signaling
(Fig. 2), but the targets of thesepathways and their reciprocal regulation
are still unclear.
The nutrient sensor IGF-1 signaling pathway was the ﬁrst to be
associated to CR-mediated regulation of life span in animals. Keyton
and coworkers ﬁrst showed that in C. elegans, loss-of-function
mutations of the daf-2 gene, which encodes a hormone receptor
similar to the IGF-1 receptor, considerably extended the life span of
the transgenic animals [60,61]. Accordingly, mutations that decrease
the activity of downstream targets such as phosphatidylinositol
3-kinase (PI3K) and AKT extend life span as well [62]. The effects of
the IGF-1 pathways on life span extension seem to be evolutionary
conserved from worm to humans [63]. Indeed in mice, the IGF-1
receptor and insulin receptor (IR) null mutants die at birth or shortly
after, due to respiratory insufﬁciency and metabolic complications,
respectively [64]. Conversely, heterozygous knockout mice for the
IGF-1 receptor (Igfr+/−) not only live longer but also show a delay in
the onset of pathologies and display greater resistance to oxidative
stress [65]. The increased resistance to oxidative damage was further
proven by a microarray gene expression analysis of daf-2 mutants of
C. elegans [66]. Indeed, many daf-2 target genes encode proteins that
are predicted to protect cells from oxidative stress such as the
metallothionein homologue mtl-1 and the mitochondrial superoxide
dismutase gene sod-3 [66]. Furthermore, cultured mouse embryonic
ﬁbroblasts (MEFs) deriving from Igfr+/− mice treated with low
concentrations of hydrogen peroxide showed a higher cell survival
than control MEFs [65], suggesting that the effects of the IGF-1
pathway on longevity are closely related to mitochondrial protection
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components of this pathway, such as age-1 (the homologue of PI3K)
and akt-1 and akt-2 (the homologue of AKT1 and AKT2), result in
extension of life span [67].
One of the most well-characterized targets of IGF-1 signaling
pathways is the target of rapamycin (TOR) protein kinase, which is
highly conserved during evolution and functions as the major amino
acid and nutrient sensor in the cell ([68] and Fig. 2). Much evidence
points out the central role of this kinase in life span extension by CR. In
yeast, C. elegans and Drosophila TOR is required for the effects of
dietary restriction, and importantly, its downregulation extends life
span of all these models [69–71]. Also treatment of mice with
rapamycin, an inhibitor of TOR activity, extends life span [72],
demonstrating that the TOR-dependent regulation of aging is highly
conserved during evolution.
TOR, in response to nutrients, upregulates translation both through
the activation of the ribosomal subunit S6K and the inhibition of the
activity of the translator inhibitor 4E BP [68]. Importantly, the inhibition
of S6K extends life span in yeast, C. elegans, andDrosophila [69,71,73]. In
mice, knocking out S6K protects against age- and diet-induced obesity
[74] and induces life span extension [75], modulating the same genes as
CR [75], suggesting TOR as one of the major player of life extension
mediated by dietary restriction.
In parallel, the life span extension mediated by the IGF-1 receptor
has been shown to be also dependent from the transcription factor daf-
16. Mammalian FoxO transcription factors, including FoxO1, FoxO3a,
FoxO4, and FoxO6, are homologues of the C. elegans daf-16 and of
Drosophila dFOXO [76]. It is known that the IGF-1/insulin signaling
pathways inhibit FoxO factors through AKT phosphorylation, thus
retaining this transcription factor in the cytoplasm and hence
repressing the FoxO transcriptional function ([77] and Fig. 2). Many
studies demonstrated that FoxO is required for the anti-aging effects of
the IGF-1 pathway inDrosophila [78] and also in C. elegans [79]. Indeed,
in ﬂies, the over-expression of FoxO is sufﬁcient to induce longevity
[80,81] in a TOR-independent fashion. Interestingly, in C. elegans, the
activation of FoxO selectively in the nervous system is sufﬁcient to
induce longevity in the whole organism, suggesting that this
transcription factor mediates the production of secondary signals
that regulates life span throughout the organism [82]. Many studies
demonstrated that FoxO can induce the expression of several
antioxidative enzymes, such as catalase, metallothionine, glutathione
S-transferase, and superoxide dismutase 2 (SOD2) [76,83,84]. Impor-
tantly, the over-expression of some of these genes is sufﬁcient to
increase life span of ﬂies andmice, as shown for the SOD2 gene [11,85].
Aging is characterized also by the impairment of the autophagic
pathway, which is an evolutionary conserved catabolic pathway that
plays a fundamental role in the degradation of damaged cytosolic
components (long-lived proteins, plasma membranes, and organelles)
[86]. Thereafter, the term autophagy will refer to the process termed as
macroautophagy, characterized by formation of double-membrane
cytosolic vesicles, the autophagosomes, that sequester the cytoplasm
or damaged organelles (e.g.,mitochondria, endoplasmic reticulum(ER),
and part of the nucleus) and deliver this cargo to the lysosome/vacuole
for degradation [87].
This highly regulated process is mediated by about 30 ATG
proteins (autophagy-related proteins), conserved form yeast to
humans, that participate to the different steps, from autophagosome
formation to its fusion with lysosomes [87]. Autophagy is generally
considered as a “survival mechanism” of eukaryotic cells in conditions
of nutrient limitation, allowing cellular macromolecules to be
degraded and recycled and, furthermore, it is crucial for degrading
damaged cellular components [88].
Aging is characterized by a signiﬁcant decrease in the rate of
degradation through the autophagic pathway caused by a consistent
decrease of the proteolytic activity of lysosomes and an impairment of
the fusion of the autophagosomes to the lysosomes [89]. This could beone of the causes that contribute to the accumulation of aberrant
macromolecules and organelles in senescent cells [90]. The causative
link between slow rates of autophagy degradation during aging and
the accumulation of damaged cellular components is supported by the
analysis of knockout and transgenic animal models for the different
ATG genes [87]. Importantly, in mice, C. elegans, and Drosophila, loss-
of-function mutations of the ATG genes lead to accumulation of
damaged proteins and organelles [91–93], leading to a substantial
shortening of life span, suggesting that autophagy is required for life
span extension. Indeed, maintaining the expression of ATG genes in
neurons of Drosophila prevents the accumulation of aberrant macro-
molecules and promotes life span extension, promoting resistance to
oxidative stress [94].
Scherz-Shouval and coworkers demonstrated that during starvation,
mammalian cells produce ROS, which seem to be essential for
autophagosome formation and autophagic degradation [95]. They also
show that treatment of mammalian cells with hydrogen peroxide
stimulates autophagy by redox regulation of ATG4 [95]. These data,
together with the analysis of autophagy deﬁcient mutants [91–93],
suggest a critical role of autophagy during aging and strengthen the idea
that ROS act as important signalingmolecules, controlling the induction
also of critical catabolic pathways. Autophagy is suggested to be crucial
also for the onset of age-related diseases. Indeed, knockout animals for
ATG5 and ATG7 in the nervous system show accumulation of abnormal
proteins and massive neuronal loss leading to neurodegereration with
decreased life span [96,97].
Autophagy is regulated by the same signaling pathways that
determine life span, and this process seems to largely contribute to
the determination of the aging speed of different animal models, acting
as one of the downstream effectors of these signaling cascades (Fig. 2).
Theﬁrstpieceof evidence cameabout20 years ago fromtheobservation
that low levels of insulin in liver induces autophagy during fasting and,
conversely, stimulation with insulin suppresses this process [98].
Afterwards, it was shown that if autophagy genes are downregulated
by RNAi (e.g., ATG12 or Beclin-1), C. elegans that carry a loss-of-function
mutation in daf-2 do not show the expected life span extension [93],
suggesting that autophagy is essential for the effects of the IGF-1/insulin
pathway on longevity. Subsequent studies demonstrated that the
insulin/IGF-1 pathway regulates autophagy through TOR and FoxO,
with opposite effects (Fig. 2). Indeed, TOR was shown to inhibit
autophagy, and the activation of autophagy was demonstrated to be
crucial for the life span extension observed in TOR knockout yeast [99]
and C. elegans [100]. In parallel, FoxO has been shown to induce
autophagy in C. elegans and mice, probably contributing to the life span
extension phenotype observed in animal models over-expressing these
transcription factors [101,102].
Recently, other signaling pathways have been shown to converge
and regulate the FoxO transcription factors and thus oxidative stress
and aging, suggesting the existence of a complex network of signaling
pathways that are modulated by different physiological and environ-
mental stimuli and converge to diminish mitochondrial oxidative
stress, ameliorating the negative effects of aging (Fig. 2).
In recent years, it has been shown that caloric restriction affects
mitochondria through a class of proteins known as sirtuins,
speciﬁcally Sir2 and its mammalian orthologue SIRT1. This group of
NAD-dependent deacetylases [103,104] increases life span in yeast
[105], C elegans [106], and Drosophila [107]. Importantly, three of
seven mammalian sirtuins (SIRT3, 4, and 5) are targeted to
mitochondria, and SIRT1 itself is a regulator of mitochondrial
biogenesis [108]. These proteins are activated during CR, when the
NAD/NADH ratio is elevated [109,110]. SIRT1 knockout mice do not
show the CR phenotype [111], and SIRT1 over-expressing mice show
decreased levels of blood glucose, insulin, fat, and cholesterol,
resembling the CR phenotype [112], indicating that protein acetyla-
tion is a crucial control mechanism in cell physiology. Brunet and
coworkers were the ﬁrst to demonstrate that SIRT1 and FoxO3 form a
264 A. Raffaello, R. Rizzuto / Biochimica et Biophysica Acta 1813 (2011) 260–268complex in response to oxidative stress [113]. Other studies
conﬁrmed that SIRT1 is part of the insulin/IGF-1 pathway, being
able to deacetylate and thus activate FoxO transcription factors, which
in turn activate stress response genes and longevity ([114–116] and
Fig. 2). Importantly, the longevity phenotype associated with SIRT1
over-expression seems to be, at least in part, due to the induction of
autophagy [117], as SIRT1 forms complexes with several ATG proteins,
which leads to their deacetylation and activation. Although the exact
mechanism of SIRT1 direct induction of autophagy is still debated,
mammalian cells from SIRT1 knockout animals are characterized by a
severe impairment of autophagy [117]. Furthermore, the accumula-
tion of damaged organelles and mitochondria was similar between
SIRT1 and ATG5 knockouts [117]. In parallel, SIRT1 can induce
indirectly the autophagic process by deacetylating and activating
FoxO transcription factors, as demonstrated by a recent study in
mouse aged kidneys [118]. A recent work of Zhao and coworkers
demonstrated that also cytosolic FoxO1 after being deacetylated by
SIRT2, in stress conditions, can induce autophagy [119], suggesting
the presence in the cell of a redundant control of autophagy that
allows to ﬁnely tune this process under a wide array of physiological
and pathological conditions.
Furthermore, SIRT1 can activate PGC-1α and therefore can
increase its ability to transcriptionally activate target genes (Fig. 2).
Peroxisome-proliferator-activated receptor γ coactivator-1 (PGC-1)
family of transcriptional coactivators interacts with chromatin
modifying enzymes, basal transcription machinery, and splicing
factors, induces transcription, and has emerged as master key
regulators of mitochondrial biogenesis [120]. Several data linked
PGC-1α and aging. First, PGC-1α is progressively downregulated
during aging, and this is prevented by CR [121]. Furthermore,
oxidative stress is known to induce the expression of this gene
[122–124]. In general, PGC-1α improves mitochondrial dysfunction,
the major phenotype of aging and age-related diseases, in a tissue-
dependent fashion (for a review, see Ref. [125]). In general, PGC-1α
translocates to the nucleus upon stress and induces the transcription
of genes involved in mitochondrial function [122]. During CR, the
activation of PGC-1α by SIRT1mediatesmitochondrial biogenesis. It is
important to point out that a greater pool of functional mitochondria
could ameliorate tissue damage by opposing cells against the gradual
energetic decline occurring in cells as mitochondria become damaged
during aging.
Also SIRT3 and SIRT4 have important metabolic functions in
mitochondria [108]. Recently, it has been shown that SIRT3 is required
for the maintenance of mitochondrial integrity and metabolism
during stress and that loss of SIRT3 results in a decreased SOD2
expression as a function of age, resulting in a considerable increase of
mitochondrial ROS [126]. The mechanism responsible for this crucial
effect is not yet clear.
AMP kinase (AMPK) is another critical regulator of mitochondrial
biogenesis in response to energy deprivation [127]. This protein
kinase is highly conserved in all eukaryotic species [128], where it acts
as a sensor of cellular energy status. Indeed, AMPK is activated by
increases in the cellular AMP:ATP ratio, leading to the activation of
catabolic pathways and to the inhibition of anabolic ones in conditions
of deprivation of nutrients [129]. The involvement of AMPK in aging
comes from the observation that this kinase is activated in response to
a variety of stimuli associated to CR, including decreased energy or
glucose levels [130]. Furthermore, over-expressing AMPK extends life
span in C. elegans [131], and in this animal model, its activation seems
to allow dietary restriction to extend life span by increasing resistance
to oxidative stress [132]. Finally, its activation by metformin can
extend life span in mice [133].
Although the mechanism by which AMPK induces life span
extension is not yet completely elucidated, it has been demonstrated
that this kinase directly phosphorylates and thus activates PGC-1α [134]
and FoxO transcription factors ([132] and Fig. 2). The AMPK-mediatedphosphorylation of FoxO transcription factors, without affecting their
subcellular localization, results in the selective induction of genes
involved in the control of energy balance and stress resistance [135].
A recent study revealed a more complicated scenario where also
SIRT1 and AMPK activities are indirectly linked, explaining many of
the convergent biological effects of AMPK and SIRT1 on the beneﬁcial
effects of CR. In this study, carried out in an in vitro muscle model
[136], it has been shown that phosphorylation of PGC-1α and FoxO
constitutes a priming signals for subsequent deacetylation by SIRT1.
The coordinated sequential activities of AMPK and SIRT1 could be a
conserved mechanism to modulate the speciﬁcity among SIRT1
targets, with phosphorylation discriminating which substrates should
be deacetylated.
4. The interplay of mitochondrial signaling pathways
The deﬁnitive picture of the signals that trigger aging and the
molecular pathways responsible for the development of senescence is
far from being elucidated. It is clear that oxidative stress is the major
trigger of the accumulation of cellular damage and that mitochondria
play a central role in producing reactive oxygen species. For this
reason, mitochondria represent the principal target of anti-aging
strategies that many organisms have developed during evolution. In
this regard, it has been shown that the adaptor protein p66shc is the
master regulator of ROS production and oxidative stress and that
knocking down this gene leads to a signiﬁcant increase in life span
([39] and Fig. 1). On the other hand, also caloric restriction, through
the modulation of IGF-1, TOR, sirtuins, and AMP kinase signaling
pathways, has been demonstrated to impinge on mitochondrial
oxidative stress amelioration ([63] and Fig. 2). Many of the known
determinants of life span are part of a complex network of signals that
coordinately modulate common targets [63]. For example, autophagy,
which seems to be required for life span extension mediated by CR
[90], is targeted bymany signalingmolecules, such as FoxO, SIRT1, and
TOR.
Of fundamental importance is extending the knowledge of the
reciprocal interplay of the age-related signals (Fig. 3). Recently, an
important study proposed that the treatment of mammalian cells with
hydrogen peroxide induces a concentration dependent increase in FoxO
phosphorylation, leading to its inactivation [137],while treatmentswith
cell permeant hydrogen peroxide scavengers induce the activation of
these transcription factors [137]. In the same study, the authors also
demonstrated that FoxO activity is regulated by intracellular ROS in a
p66shc-dependent fashion, suggesting the existence of an important
functional interaction between FoxO transcription factors and p66shc
([137] and Fig. 3). Another study showed in the adipose tissue that
p66shc is a downstreamtarget of the insulin/IGF-1anda criticalmediator
of insulin-dependent ROS upregulation in adipocytes [53], being able to
control Akt phosphorylation and FoxO1 localization [53]. Finally, the
long-lived Igf1r+/− mutants also show an underphosphorylation of
p66shc [65], and importantly, p66shc mutants, defective of the
phosphorylation and redox activities, are unable to reestablish the
antioxidant response by insulin [53], suggesting a possible mechanism
that links caloric restriction to oxidative stress. Despite the new
discoveries that suggest a clear connection between p66shc and the
pathway regulated by CR (e.g., IGF-1 pathway), the role of p66shc in the
regulation of autophagy still remains to be elucidated, aswell as and the
interplay with the other pathways in modulating this crucial process.
In addition, other signaling inputs converge on mitochondria and
affect the efﬁciency of the positive (CR) or negative (oxidative stress)
cellular challenges and the ﬁnal outcome. Among those, a primary role
is played by calcium ions. Long-standing evidence links calcium
dysregulation to cell death by apoptosis and necrosis, and recent work
has provided a deep insight into the molecular mechanisms and
pathophysiological relevance of the calcium-mediated effects. We
covered this topic in recent reviews and refer to these articles for a
Fig. 3. Interplay between the signaling pathways controlling mitochondrial ROS
production. Caloric restriction, the IGF-1/insulin pathway, and oxidative stress are
known inducers of mitochondrial ROS production. The downstream signaling pathways
that mediate this cellular response are closely interrelated. Indeed, SIRT1, activated by
caloric restriction, deacetylates and thus activates the FoxO transcription factors, whose
phosphorylation is controlled by the IGF-1 pathway. Furthermore, the adaptor protein
p66shc, which directly regulates mitochondrial ROS production, inhibits FoxO
activation.
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experimental data, however, is also highlighting a role for calcium
homeostasis in the control of autophagy, the process of cell death/
stress adaptation that has been discussed in this review. On the one
hand, a major rise in cytoplasmic Ca2+ concentration (e.g., by agonist
or pharmacological depletion of the ER store) is a potent inducer of
autophagy [141], and inactivation of the only isoform of the inositol
1,4,5-trisphosphate receptor (IP3R) present in Dicytostelium prevents
autophagic cell death [142]. On the other hand, the pharmacological
inhibition or siRNA silencing of the IP3R stimulates autophagy [143],
and chicken DT40 cell lines containing targeted deletions of all three
IP3R isoforms [144] exhibit enhanced basal autophagic ﬂuxes also in
the presence of nutrients. The IP3R interacts with both Beclin-1 and
Bcl-2, and displacement of Beclin-1 (upon pharmacological inhibition
of the IP3Ror downregulationof Bcl-2) promotes autophagy [145]. The
complexity of the macromolecular interaction has been further
highlighted by the isolation of the nutrient deprivation autophagy
factor-1 (NAF-1), an integral membrane protein that is found
associated to the IP3R and is required for Bcl-2-dependent inhibition
of Beclin-1-dependent autophagy [146]. It is thus clear that in the ﬁne
equilibrium between autophagy and apoptosis, and thus in the
regulation of the mechanisms that underlie tissue damage or,
conversely, resistance to oxidative and other cell challenges, intracel-
lular Ca2+ channels play a pivotal role, in at least two ways. The ﬁrst
depends onCa2+ signal itself, as global ormore likely local signals (e.g.,
those at the ER/mitochondria interphase) sustain fundamental cell
functions or conversely sensitize to cell death promoting challenges
[138–140]. The second mechanism is the involvement of Ca2+
channels in macromolecular complexes regulating, in opposite ways,
the two cell death pathways. In this context, the alternative expression
of different isoforms, as well as their regulation by phosphorylation,
cleavage or Ca2+ itself may represent further control steps.
In all cases, it is easy to predict that in the following years, the
integration of the vast evidence on the role of oxidative stress and
nutrition-dependent signaling pathways, summarized in this review,
with the emerging concepts derived from Ca2+ homeostasis will
further deepen our molecular understanding of the process of aging
and of the role of mitochondria as inducers, scaffolds, or ﬁnal targets
of the processes controlling cell fate and organism life span.Overall, the data discussed in this review demonstrate that the
generation of ROS within the mitochondria remains the most widely
accepted cause of aging. Moreover, the different signaling pathways
converging on the regulation of mitochondria redox status is tightly
interconnected (Fig. 3), suggesting the existence of a complex and
highly regulated “life span machinery” that has been conserved
during evolution. FoxO transcription factors, the histone deacetylases
sirtuins, IGF-1 pathway, TOR, AMP kinase, and the adaptor proteins
p66shc are all involved in either regulating the level of intracellular
ROS in mammal cells or increasing oxidative stress resistance.
Although several new discoveries have answered fundamental
questions on aging regulation, substantial gaps and unknowns still
persist. The use of animal models of longevity has been crucial in
deciphering the signals and components of the aging process, but it is
necessary to achieve information also on the human control of aging
exerted bymitochondria. The future studies will shed new light in this
fascinating process and contribute to develop new therapies for the
amelioration of age-dependent diseases.
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